Drug profile · INN
secobarbital sodium
SECONAL SODIUM
secobarbital sodium (SECONAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
Drug details — secobarbital sodium
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
secobarbital sodium (SECONAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is secobarbital sodium?
secobarbital sodium (SECONAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for secobarbital sodium?
SECONAL SODIUM is a marketed brand name for secobarbital sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of secobarbital sodium?
secobarbital sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.